CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $311,000 | -3.4% | 156,531 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $322,000 | -3.9% | 156,531 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $335,000 | -24.9% | 156,531 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $446,000 | -35.8% | 156,531 | 0.0% | 0.01% | -42.9% |
| Q3 2015 | $695,000 | -13.4% | 156,531 | 0.0% | 0.01% | -6.7% |
| Q2 2015 | $803,000 | -27.7% | 156,531 | 0.0% | 0.02% | -28.6% |
| Q1 2015 | $1,111,000 | -36.4% | 156,531 | -37.4% | 0.02% | -38.2% |
| Q4 2014 | $1,748,000 | +15.4% | 250,000 | 0.0% | 0.03% | +6.2% |
| Q3 2014 | $1,515,000 | -76.8% | 250,000 | -65.2% | 0.03% | -77.0% |
| Q2 2014 | $6,539,000 | -10.7% | 718,604 | -20.2% | 0.14% | -16.8% |
| Q1 2014 | $7,326,000 | -2.9% | 900,604 | -23.2% | 0.17% | -6.7% |
| Q4 2013 | $7,544,000 | -24.8% | 1,173,411 | +17.0% | 0.18% | -33.2% |
| Q3 2013 | $10,032,000 | – | 1,003,091 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |